跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RYBELSUS semaglutide 3 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RYBELSUS semaglutide 3 mg tablet blister pack
Approved
STANDARD
RYBELSUS semaglutide 3 mg tablet blister pack
Novo Nordisk Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
cb77ec8864776f5c
Company
Novo Nordisk Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
cb77ec8864776f5c
Product Name
RYBELSUS semaglutide 3 mg tablet blister pack
Artg Id
346198
Artg Name
RYBELSUS semaglutide 3 mg tablet blister pack
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path
/organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date
2022-02-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
cb77ec8864776f5c
Type
Standard
Back to TGA Approvals
